The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nucleic Acid Vaccine Market Research Report 2025
Synopsis
A nucleic acid vaccine is to directly introduce an exogenous gene (DNA or RNA) encoding an antigen protein into an animal body cell, and synthesize the antigen protein through an expression system of a host cell to induce the host to produce an immune response to the antigen protein to achieve prevention And the purpose of treating the disease.
The global Nucleic Acid Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Vaccine.
Report Scope
The Nucleic Acid Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna
CureVac
Inovio
Sanofi
GSK
CNBG
Hualan Bio
Zhifei Shengwu
Liaoning Chengda
BioKangtai
CanSinoBIO
Walvax Biotechnology
Fosun Pharma
Segment by Type
Preventive Nucleic Acid Vaccine
Therapeutic Vucleic Acid Vaccine
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nucleic Acid Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nucleic Acid Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A nucleic acid vaccine is to directly introduce an exogenous gene (DNA or RNA) encoding an antigen protein into an animal body cell, and synthesize the antigen protein through an expression system of a host cell to induce the host to produce an immune response to the antigen protein to achieve prevention And the purpose of treating the disease.
The global Nucleic Acid Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Vaccine.
Report Scope
The Nucleic Acid Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna
CureVac
Inovio
Sanofi
GSK
CNBG
Hualan Bio
Zhifei Shengwu
Liaoning Chengda
BioKangtai
CanSinoBIO
Walvax Biotechnology
Fosun Pharma
Segment by Type
Preventive Nucleic Acid Vaccine
Therapeutic Vucleic Acid Vaccine
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nucleic Acid Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nucleic Acid Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nucleic Acid Vaccine Market Overview
1.1 Product Overview and Scope of Nucleic Acid Vaccine
1.2 Nucleic Acid Vaccine Segment by Type
1.2.1 Global Nucleic Acid Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Preventive Nucleic Acid Vaccine
1.2.3 Therapeutic Vucleic Acid Vaccine
1.3 Nucleic Acid Vaccine Segment by Application
1.3.1 Global Nucleic Acid Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Nucleic Acid Vaccine Market Size Estimates and Forecasts
1.4.1 Global Nucleic Acid Vaccine Revenue 2019-2030
1.4.2 Global Nucleic Acid Vaccine Sales 2019-2030
1.4.3 Global Nucleic Acid Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nucleic Acid Vaccine Market Competition by Manufacturers
2.1 Global Nucleic Acid Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nucleic Acid Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nucleic Acid Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Nucleic Acid Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nucleic Acid Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nucleic Acid Vaccine, Product Type & Application
2.7 Nucleic Acid Vaccine Market Competitive Situation and Trends
2.7.1 Nucleic Acid Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nucleic Acid Vaccine Players Market Share by Revenue
2.7.3 Global Nucleic Acid Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nucleic Acid Vaccine Retrospective Market Scenario by Region
3.1 Global Nucleic Acid Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nucleic Acid Vaccine Global Nucleic Acid Vaccine Sales by Region: 2019-2030
3.2.1 Global Nucleic Acid Vaccine Sales by Region: 2019-2024
3.2.2 Global Nucleic Acid Vaccine Sales by Region: 2025-2030
3.3 Global Nucleic Acid Vaccine Global Nucleic Acid Vaccine Revenue by Region: 2019-2030
3.3.1 Global Nucleic Acid Vaccine Revenue by Region: 2019-2024
3.3.2 Global Nucleic Acid Vaccine Revenue by Region: 2025-2030
3.4 North America Nucleic Acid Vaccine Market Facts & Figures by Country
3.4.1 North America Nucleic Acid Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nucleic Acid Vaccine Sales by Country (2019-2030)
3.4.3 North America Nucleic Acid Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nucleic Acid Vaccine Market Facts & Figures by Country
3.5.1 Europe Nucleic Acid Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nucleic Acid Vaccine Sales by Country (2019-2030)
3.5.3 Europe Nucleic Acid Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nucleic Acid Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Nucleic Acid Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nucleic Acid Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Nucleic Acid Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nucleic Acid Vaccine Market Facts & Figures by Country
3.7.1 Latin America Nucleic Acid Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nucleic Acid Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Nucleic Acid Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nucleic Acid Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Nucleic Acid Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nucleic Acid Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nucleic Acid Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nucleic Acid Vaccine Sales by Type (2019-2030)
4.1.1 Global Nucleic Acid Vaccine Sales by Type (2019-2024)
4.1.2 Global Nucleic Acid Vaccine Sales by Type (2025-2030)
4.1.3 Global Nucleic Acid Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Nucleic Acid Vaccine Revenue by Type (2019-2030)
4.2.1 Global Nucleic Acid Vaccine Revenue by Type (2019-2024)
4.2.2 Global Nucleic Acid Vaccine Revenue by Type (2025-2030)
4.2.3 Global Nucleic Acid Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Nucleic Acid Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nucleic Acid Vaccine Sales by Application (2019-2030)
5.1.1 Global Nucleic Acid Vaccine Sales by Application (2019-2024)
5.1.2 Global Nucleic Acid Vaccine Sales by Application (2025-2030)
5.1.3 Global Nucleic Acid Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Nucleic Acid Vaccine Revenue by Application (2019-2030)
5.2.1 Global Nucleic Acid Vaccine Revenue by Application (2019-2024)
5.2.2 Global Nucleic Acid Vaccine Revenue by Application (2025-2030)
5.2.3 Global Nucleic Acid Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Nucleic Acid Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Corporation Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Moderna Nucleic Acid Vaccine Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 CureVac
6.2.1 CureVac Corporation Information
6.2.2 CureVac Description and Business Overview
6.2.3 CureVac Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CureVac Nucleic Acid Vaccine Product Portfolio
6.2.5 CureVac Recent Developments/Updates
6.3 Inovio
6.3.1 Inovio Corporation Information
6.3.2 Inovio Description and Business Overview
6.3.3 Inovio Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Inovio Nucleic Acid Vaccine Product Portfolio
6.3.5 Inovio Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Nucleic Acid Vaccine Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 GSK
6.5.1 GSK Corporation Information
6.5.2 GSK Description and Business Overview
6.5.3 GSK Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GSK Nucleic Acid Vaccine Product Portfolio
6.5.5 GSK Recent Developments/Updates
6.6 CNBG
6.6.1 CNBG Corporation Information
6.6.2 CNBG Description and Business Overview
6.6.3 CNBG Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CNBG Nucleic Acid Vaccine Product Portfolio
6.6.5 CNBG Recent Developments/Updates
6.7 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hualan Bio Nucleic Acid Vaccine Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 Zhifei Shengwu
6.8.1 Zhifei Shengwu Corporation Information
6.8.2 Zhifei Shengwu Description and Business Overview
6.8.3 Zhifei Shengwu Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zhifei Shengwu Nucleic Acid Vaccine Product Portfolio
6.8.5 Zhifei Shengwu Recent Developments/Updates
6.9 Liaoning Chengda
6.9.1 Liaoning Chengda Corporation Information
6.9.2 Liaoning Chengda Description and Business Overview
6.9.3 Liaoning Chengda Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Liaoning Chengda Nucleic Acid Vaccine Product Portfolio
6.9.5 Liaoning Chengda Recent Developments/Updates
6.10 BioKangtai
6.10.1 BioKangtai Corporation Information
6.10.2 BioKangtai Description and Business Overview
6.10.3 BioKangtai Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 BioKangtai Nucleic Acid Vaccine Product Portfolio
6.10.5 BioKangtai Recent Developments/Updates
6.11 CanSinoBIO
6.11.1 CanSinoBIO Corporation Information
6.11.2 CanSinoBIO Nucleic Acid Vaccine Description and Business Overview
6.11.3 CanSinoBIO Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 CanSinoBIO Nucleic Acid Vaccine Product Portfolio
6.11.5 CanSinoBIO Recent Developments/Updates
6.12 Walvax Biotechnology
6.12.1 Walvax Biotechnology Corporation Information
6.12.2 Walvax Biotechnology Nucleic Acid Vaccine Description and Business Overview
6.12.3 Walvax Biotechnology Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Walvax Biotechnology Nucleic Acid Vaccine Product Portfolio
6.12.5 Walvax Biotechnology Recent Developments/Updates
6.13 Fosun Pharma
6.13.1 Fosun Pharma Corporation Information
6.13.2 Fosun Pharma Nucleic Acid Vaccine Description and Business Overview
6.13.3 Fosun Pharma Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Fosun Pharma Nucleic Acid Vaccine Product Portfolio
6.13.5 Fosun Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nucleic Acid Vaccine Industry Chain Analysis
7.2 Nucleic Acid Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nucleic Acid Vaccine Production Mode & Process
7.4 Nucleic Acid Vaccine Sales and Marketing
7.4.1 Nucleic Acid Vaccine Sales Channels
7.4.2 Nucleic Acid Vaccine Distributors
7.5 Nucleic Acid Vaccine Customers
8 Nucleic Acid Vaccine Market Dynamics
8.1 Nucleic Acid Vaccine Industry Trends
8.2 Nucleic Acid Vaccine Market Drivers
8.3 Nucleic Acid Vaccine Market Challenges
8.4 Nucleic Acid Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
